Search

Your search keyword '"Ansotegui, Ignacio"' showing total 707 results

Search Constraints

Start Over You searched for: Author "Ansotegui, Ignacio" Remove constraint Author: "Ansotegui, Ignacio"
707 results on '"Ansotegui, Ignacio"'

Search Results

51. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

52. A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020

53. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

54. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

56. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

57. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

58. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

59. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

60. Doxofylline as a steroid-sparing treatment in Mexican children with asthma.

61. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – X – Breastfeeding a baby with cow's milk allergy

65. The global impact of the DRACMA guidelines cow’s milk allergy clinical practice

67. The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update

68. Green roof gardens – Selecting allergy friendly vegetation: a GA2LEN position paper

69. World Health Organization (WHO) guideline on the complementary feeding of infants and young children aged 6−23 months 2023: A multisociety response

72. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem

73. In-flight allergic emergencies

75. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

76. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

77. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

78. Particularities of allergy in the Tropics

79. International survey on skin patch test procedures, attitudes and interpretation

83. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

84. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air approach.

85. Consistent trajectories of rhinitis control and treatment in 16,177 weeks : the MASK-air® longitudinal study

86. Patient-centered digital biomarkers for allergic respiratory diseases and asthma:The ARIA-EAACI approach – ARIA-EAACI Task Force Report

87. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach

88. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air (R) longitudinal study

89. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

90. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

91. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

92. Consistent trajectories of rhinitis control and treatment in 16,177 weeks

93. Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization

94. The ARIA-MASK-air® approach

95. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

96. Cutoff Values of MASK-air Patient-Reported Outcome Measures

97. Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey

98. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK‐air® longitudinal study

99. Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities

Catalog

Books, media, physical & digital resources